Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText.
Kick-your-searchterm to multiple Engines kick-your-query now !>
A dictionary by aggregated review articles of nephrology, medicine and the life sciences
Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

suck abstract from ncbi


10.3389/fimmu.2020.01472

http://scihub22266oqcxt.onion/10.3389/fimmu.2020.01472
suck pdf from google scholar
32655579!7325923!32655579
unlimited free pdf from europmc32655579    free
PDF from PMC    free
html from PMC    free

suck abstract from ncbi


Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534

Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534
pmid32655579      Front+Immunol 2020 ; 11 (ä): 1472
Nephropedia Template TP

gab.com Text

Twit Text FOAVip

Twit Text #

English Wikipedia


  • Intoxication With Endogenous Angiotensin II: A COVID-19 Hypothesis #MMPMID32655579
  • Sfera A; Osorio C; Jafri N; Diaz EL; Campo Maldonado JE
  • Front Immunol 2020[]; 11 (ä): 1472 PMID32655579show ga
  • Severe acute respiratory syndrome coronavirus 2 has spread rapidly around the globe. However, despite its high pathogenicity and transmissibility, the severity of the associated disease, COVID-19, varies widely. While the prognosis is favorable in most patients, critical illness, manifested by respiratory distress, thromboembolism, shock, and multi-organ failure, has been reported in about 5% of cases. Several studies have associated poor COVID-19 outcomes with the exhaustion of natural killer cells and cytotoxic T cells, lymphopenia, and elevated serum levels of D-dimer. In this article, we propose a common pathophysiological denominator for these negative prognostic markers, endogenous, angiotensin II toxicity. We hypothesize that, like in avian influenza, the outlook of COVID-19 is negatively correlated with the intracellular accumulation of angiotensin II promoted by the viral blockade of its degrading enzyme receptors. In this model, upregulated angiotensin II causes premature vascular senescence, leading to dysfunctional coagulation, and immunity. We further hypothesize that angiotensin II blockers and immune checkpoint inhibitors may be salutary for COVID-19 patients with critical illness by reversing both the clotting and immune defects (Graphical Abstract).
  • |*Up-Regulation[MESH]
  • |Age Factors[MESH]
  • |Angiotensin II/*blood[MESH]
  • |Angiotensin Receptor Antagonists/therapeutic use[MESH]
  • |Angiotensin-Converting Enzyme 2[MESH]
  • |Angiotensin-Converting Enzyme Inhibitors/therapeutic use[MESH]
  • |Betacoronavirus/*metabolism[MESH]
  • |Brain/immunology/metabolism[MESH]
  • |COVID-19[MESH]
  • |Cellular Senescence/drug effects[MESH]
  • |Coronavirus Infections/*blood/drug therapy/*physiopathology/virology[MESH]
  • |Critical Illness[MESH]
  • |Cytokines/metabolism[MESH]
  • |Dopamine/metabolism[MESH]
  • |Down-Regulation[MESH]
  • |Humans[MESH]
  • |Immunotherapy/methods[MESH]
  • |Mitochondria/metabolism[MESH]
  • |Pandemics[MESH]
  • |Peptidyl-Dipeptidase A/metabolism[MESH]
  • |Pneumonia, Viral/*blood/drug therapy/*physiopathology/virology[MESH]
  • |Prognosis[MESH]
  • |Renin-Angiotensin System/immunology[MESH]


  • DeepDyve
  • Pubget Overpricing
  • suck abstract from ncbi

    Linkout box